What is the main focus of treatment for spondyloarthropathies?

The main focus of treatment for spondyloarthropathies centers on the treatment of the underlying disease process, particularly through the use of biologic medications and disease-modifying antirheumatic drugs (DMARDs). Spondyloarthropathies, such as ankylosing spondylitis and psoriatic arthritis, involve chronic inflammation of the joints, spine, and, in some cases, extra-articular manifestations. The primary aim is to target the underlying inflammation and disease progression, which can lead to significant long-term morbidity if not effectively managed.

By addressing the underlying disease, treatment can reduce the frequency and severity of symptoms, minimize structural damage to joints and surrounding tissues, and improve quality of life. Early and aggressive treatment is often advocated to prevent irreversible changes associated with these conditions.

In contrast, while symptom management, palliative care, and physical therapy are certainly components of a comprehensive management plan, they do not target the fundamental pathology of spondyloarthropathies. Symptom management focuses on alleviating pain and stiffness, palliative care is concerned with providing relief from the symptoms and stress of the disease without curative intent, and physical therapy plays an important supportive role in maintaining mobility and function but does not address the